Moreover, there appears to be a dose-dependent relationship between PD-L1 upregulation and chemopreventive or cytotoxic agents as, for example, in decitabine and cisplatin administered in leukemia and hepatoma cells, respectively [28,29]. This evidence concerns the gene CD274 and hepatocellular carcinoma.